TURKCELL ILETISIM HIZMETLERI A S (TKC) earnings per share

TURKCELL ILETISIM HIZMETLERI A S reports in TRY; the per-share figures below are in TRY as filed with SEC EDGAR, not US dollars.
Annual history
Fiscal years 2019 – 2021
TRY / SHARE 5 PERIODS
Period End Diluted Filed
FY 2021 2023-12-31 TRY 5.75 2022-04-14
FY 2021 2022-12-31 TRY 3.15 2022-04-14
FY 2020 2021-12-31 TRY 3.27 2021-04-26
FY 2020 2020-12-31 TRY 2.10 2021-04-26
FY 2019 2019-12-31 TRY 1.49 2020-04-02
Free cash flow per share — Annual
Fiscal years 2019 – 2021 · (Operating CF − CapEx) ÷ Diluted Shares
TRY / SHARE 5 PERIODS
Period End FCF / Share Filed
FY 2021 2023-12-31 TRY 12.62 2022-04-14
FY 2021 2022-12-31 TRY 12.32 2022-04-14
FY 2020 2021-12-31 TRY 19.97 2021-04-26
FY 2020 2020-12-31 TRY 5.83 2021-04-26
FY 2019 2019-12-31 TRY 2.65 2020-04-02

Methodology

Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. FCF / Share is computed as (Operating Cash Flow − Capital Expenditures) ÷ Diluted Shares Outstanding. When SEC companyfacts omits the direct diluted-share concept for an older period, we imply it from NetIncomeLoss ÷ EarningsPerShareDiluted. For financial filers whose operating cash flow includes customer-fund activity (e.g. Mercado Pago deposits), FCF may materially exceed net income because the fintech float is recorded inside OCF under US GAAP. Per-share values are split-adjusted to the current share count (5 split s since 2001).

For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.

FCF source tags per fiscal year (5 periods)

The exact namespace:concept that fed Operating Cash Flow, CapEx, and the diluted-share denominator for each annual FCF / Share value. Filers swap between fallback concepts over the years (e.g. PaymentsToAcquireProductiveAssetsPaymentsToAcquirePropertyPlantAndEquipment), and older periods where SEC companyfacts omits the direct shares tag fall back to an implied share count from Net Income ÷ EPS Diluted.

Period Operating CF CapEx Diluted Shares
FY 2019 ifrs-full:CashFlowsFromUsedInOperatingActivities ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities implied ifrs-full:ProfitLoss ÷ ifrs-full:DilutedEarningsLossPerShare
FY 2020 ifrs-full:CashFlowsFromUsedInOperatingActivities ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities implied ifrs-full:ProfitLoss ÷ ifrs-full:DilutedEarningsLossPerShare
FY 2020 ifrs-full:CashFlowsFromUsedInOperatingActivities ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities implied ifrs-full:ProfitLoss ÷ ifrs-full:DilutedEarningsLossPerShare
FY 2021 ifrs-full:CashFlowsFromUsedInOperatingActivities ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities implied ifrs-full:ProfitLoss ÷ ifrs-full:DilutedEarningsLossPerShare
FY 2021 ifrs-full:CashFlowsFromUsedInOperatingActivities ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities implied ifrs-full:ProfitLoss ÷ ifrs-full:DilutedEarningsLossPerShare

TKC CIK 0001071321 Source: EDGAR filings · all facts

Related tickers

FICO

Fair Isaac Corp

OPRX

OptimizeRx Corp

ZVSA

ZYVERSA THERAPEUTICS, INC.